Green Light for InVivo’s Spinal Cord Repair Device Study

It’s all happening at InVivo Therapeutics. In a flurry of news releases the company has appointed a new CEO, gained conditional approval to commence its US trial and gone ahead and satisfied the conditions with a series of responses to the FDA’s outstanding issues. The study will commence with first patients in early March.